Carbon Monoxide Poisoning
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
City TherapeuticsMA - Cambridge
1 programComparison of the Effectiveness of Treatments in Carbon Monoxide IntoxicationsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
City TherapeuticsComparison of the Effectiveness of Treatments in Carbon Monoxide Intoxications
NoninPulse Oximeter
MasimoPulse Oximeter
Clinical Trials (3)
Total enrollment: 849 patients across 3 trials
NCT06198595City TherapeuticsComparison of the Effectiveness of Treatments in Carbon Monoxide Intoxications
Comparison of the Effectiveness of Treatments in Carbon Monoxide Intoxications
Start: Nov 2023Est. completion: Jul 2024
N/ACompleted
Dysfunctional Hemoglobin Pulse Oximetry
Start: Feb 2017Est. completion: Apr 201736 patients
N/ACompleted
Utility of Non-invasive Carboxyhemoglobin and Total Hemoglobin Measurement in the Emergency Department
Start: Nov 2016Est. completion: Dec 2017813 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.